ArticleVaccine2019

Increasing FIM2/3 antigen-content improves efficacy of Bordetella pertussis vaccines in mice in vivo without altering vaccine-induced human reactogenicity biomarkers in vitro.

Anne Marie Queenan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.